Andrew R Allen Sierra Oncology, Inc. (SRRA) insider trading activity

SRRA Quotes by TradingView

Andrew R Allen is Director of Sierra Oncology, Inc.. Currently has a direct ownership of 0 shares of SRRA, which is worth approximately $0. The most recent transaction as insider was on Jul 01, 2022, when has been sold 1,650 shares (Common Stock) at a price of $55.0 per share, resulting in proceeds of $90,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Andrew R Allen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 01 2022
SELL
Sale (or disposition) back to the issuer
$90,750 $55.0 p/Share
1,650 Reduced 100.0%
0 Common Stock

Also insider at

ADAP
Adaptimmune Therapeutics PLC Healthcare
Director
GRTS
Gritstone bio, Inc. Healthcare
PRESIDENT AND CEO
EPZM
Epizyme, Inc. Healthcare
Director
TCRR
TCR2 THERAPEUTICS INC. Healthcare
Director
ARA

Andrew R Allen

Director
Cambridge, MA

Track Institutional and Insider Activities on SRRA

Follow Sierra Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRRA shares.

Notify only if

Insider Trading

Get notified when an Sierra Oncology, Inc. insider buys or sells SRRA shares.

Notify only if

News

Receive news related to Sierra Oncology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SRRA